Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)
Clinical trial NCT00409188 · COMPLETED
Trial details
- NCT number
- NCT00409188
- Sponsor
- EMD Serono
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2012-04-01
- Enrollment
- 1513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.